WOCKPHARMA — Wockhardt Share News
0.000.00%
Last trade - 00:00- IN₹317.66bn
- IN₹337.11bn
- IN₹33.73bn
Brief: Wockhardt Limited June-Quarter Consol Net Profit 1.06 Billion Rupees
India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH
Brief: Wockhardt Says Indian Drug Regulator Grants Marketing Authorization To Co's Zaynich
India's Wockhardt hits 7‑month high after swinging to profit in fourth quarter
Brief: Wockhardt Approved Enabling Proposal For Fund Raising Via Equity Or Securities
Brief: Wockhardt March-Quarter Consol Net PAT 1.66 Billion Rupees
Brief: Wockhardt Says Zaynich Receives Favourable Recommendation From CDSCO Subject Expert Committee
Brief: Wockhardt Ltd Dec-Quarter Consol Net Pat 590 Million Rupees
Brief: Wockhardt Says Foviscu Meets Main Goal In Phase 3 Trial
Brief: Wockhardt Files Marketing Authorisation Application For WCK 5222 With European Medicines Agency
Brief: Wockhardt Says EMA Grants Accelerated Assessment To Wck 5222
India's Wockhardt rises as EU regulator clears drug for accelerated assessment
Indian pharmas to benefit from potential US funding curbs on Chinese firms, Citi says
Brief: Wockhardt says USFDA Accepts Co's NDA For Antibiotic Zaynich
India's Wockhardt jumps; US FDA accepts application for antibiotic Zaynich
Brief: Shukra Pharmaceuticals Says Authorized By Wockhardt For Pan India Distribution
Brief: Wockhardt June-Qtr Consol Net Loss After Tax 900 Mln Rupees
India's Wockhardt up on plans to shut down loss-making US business
Brief: Wockhardt Initiates Strategic Realignment Of US Operations To Focus On Innovative Portfolio